help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, K. L.
Right arrow Articles by Cummings, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, K. L.
Right arrow Articles by Cummings, S. R.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 3 1217-1221
Copyright © 2004 by The Endocrine Society

Low Serum Vitamin B-12 Levels Are Associated with Increased Hip Bone Loss in Older Women: A Prospective Study

Katie L. Stone, Douglas C. Bauer, Deborah Sellmeyer and Steven R. Cummings

Departments of Epidemiology and Biostatistics (D.C.B., S.R.C.) and Medicine (K.L.S., D.C.B.) and Division of Endocrinology and Metabolism (D.S.), University of California, San Francisco, California 94105

Address all correspondence and requests for reprints to: Dr. Katie L. Stone, University of California, 74 New Montgomery Street, Suite 600, San Francisco, California 94105. E-mail: kstone{at}psg.ucsf.edu.

The purpose of this study was to test whether low serum vitamin B-12 levels are associated with more rapid bone loss in elderly women. We archived sera and measured calcaneal bone mineral density (BMD) in community-dwelling white women, aged 65 yr and over, who participated in the Study of Osteoporotic Fractures. BMD of the hip and subregions was measured 2 yr later. Repeat measurements of calcaneal and hip BMD were obtained after 5.9 and 3.5 yr of follow-up, respectively. Serum vitamin B-12 assays were performed in 83 randomly selected participants with initial and repeat measurements of BMD who were not taking estrogen replacement therapy at baseline. After adjusting for age, weight, and clinic site, women with vitamin B-12 levels at or below 280 pg/ml (207.2 pmol/liter; lowest quintile) experienced an annual change of -1.6% (95% confidence interval, -2.4% to -0.8%) in total hip BMD, compared with -0.2% (-0.5% to 0.2%) in women with levels above 280 pg/ml (P = 0.003). Results were similar when subregions of the hip were analyzed separately. Serum vitamin B-12 levels were not significantly associated with calcaneal bone loss. We conclude that low serum vitamin B-12 levels are associated with increased rates of hip, but not calcaneal, bone loss in older women.

This work was supported by USPHS Grants AG-05407, AR-35582, AG-05394, AR-35584, and AR-35583.

Abbreviations: BAP, Bone-specific alkaline phosphatase; BMD, bone mineral density; 25(OH)D, 25-hydroxyvitamin D.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. R. McLean, P. F. Jacques, J. Selhub, L. Fredman, K. L. Tucker, E. J. Samelson, D. P. Kiel, L. A. Cupples, and M. T. Hannan
Plasma B Vitamins, Homocysteine, and Their Relation with Bone Loss and Hip Fracture in Elderly Men and Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2206 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. J Green, J. A McMahon, C M. Skeaff, S. M Williams, and S. J Whiting
Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 460 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
R. R. Miller, A. R. Cappola, M. D. Shardell, W. G. Hawkes, J. A. Yu-Yahiro, J. R. Hebel, and J. Magaziner
Persistent changes in interleukin-6 and lower extremity function following hip fracture.
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1053 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Herrmann, T. Widmann, G. Colaianni, S. Colucci, A. Zallone, and W. Herrmann
Increased Osteoclast Activity in the Presence of Increased Homocysteine Concentrations
Clin. Chem., December 1, 2005; 51(12): 2348 - 2353.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. Ravaglia, P. Forti, F. Maioli, L. Servadei, M. Martelli, N. Brunetti, L. Bastagli, D. Cucinotta, and E. Mariani
Folate, But Not Homocysteine, Predicts the Risk of Fracture in Elderly Persons
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1458 - 1462.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Stone, D. Sellmeyer, D. C. Bauer, and S. R. Cummings
Authors' Response: Low Vitamin B12 and Bone Loss: A Role for Folate Deficiency
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4771 - 4772.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, M. Cannoletta, F. Baldassari, and A. Volpe
Low Vitamin B12 and Bone Loss: A Role for Folate Deficiency
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4770 - 4771.
[Full Text] [PDF]


Home page
NEJMHome page
L. G. Raisz
Homocysteine and Osteoporotic Fractures -- Culprit or Bystander?
N. Engl. J. Med., May 13, 2004; 350(20): 2089 - 2090.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society